Overview

Entecavir for Chronic Hepatitis B

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to asses the efficacy (both virological and clinical) and safety of ETV in both NA-naïve and NA-experienced chronic hepatitis B patients, and to explore baseline factors associated with virologic reponse (VR) to ETV.
Details
Lead Sponsor:
Foundation for Liver Research
Treatments:
Entecavir